The COVID-19 Immunity Task Force (CITF) is one of the Government of Canada's early efforts to track the 2020 coronavirus pandemic.[1] An external, dedicated secretariat was established in order to maximize the efficiency of the CITF's work.[2]
The CITF Board is composed of doctors, infectious disease experts, and policy makers.[1][3]
The CCITF leadership group expanded on 2 May 2020.[4] Its additional members as of March 2022 are:
The CITF was to use a serology "to survey representative samples of the population for the presence of antibodies to the virus".[5] Trudeau's press release on 23 April 2020, on the initiation of the CCITF listed several goals it would help to achieve notably that it would:[2]
establish priorities and oversee the coordination of a series of country-wide blood test surveys that will tell us how widely the virus has spread in Canada and provide reliable estimates of potential immunity and vulnerabilities in Canadian populations.
A Vaccine Surveillance Reference Group (VSRG) was also established within the CITF to monitor the safety and effectiveness of COVID-19 vaccines made available in Canada.[6]
| Locations |
| ||||||
|---|---|---|---|---|---|---|---|
| Government response |
| ||||||
| Outbreak sites | |||||||
| Vaccination | |||||||
| Public health officers | |||||||
| Culture | |||||||
| Miscellaneous | |||||||